Chad Therapeutics Reports Net Loss in 3rd Quarter

Chad Therapeutics Inc. in Chatsworth announced a net loss for the third quarter ended Dec. 31 of $683,000 compared with a net loss of $894,000 for the same period the previous year. Revenue decreased slightly to $2.96 million from $2.98 million.

Chad Therapeutics produces and distributes supplementary oxygen systems and devices for the health-care industry.